[H931-2am] 17. Biofunctional Chemistry, Biotechnology

10:40 AM - 10:50 AM JST(1:40 AM - 1:50 AM UTC)Japanese

[H931-2am-09] Transforming cancer metabolites into anticancer drugs with biocompatible transition metal catalysts

○Masayuki Kawai¹, Thung-che Chang¹, Ambara Rachmat Pradipta¹, Katsunori Tanaka^1,2 (1. Tokyo Institute of Technology, School of Materials and Chemical Technology, Department of Chemical Science and Engineering, 2. RIKEN Cluster for Pioneering Research, Biofunctional Synthetic Chemistry Laboratory)

Keywords:

Cancer treatment,Cancer metabolites,Transition metal catalyst,In vivo synthesis,Heterocycles